1. Home
  2. SIMO vs NTLA Comparison

SIMO vs NTLA Comparison

Compare SIMO & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIMO
  • NTLA
  • Stock Information
  • Founded
  • SIMO 1995
  • NTLA 2014
  • Country
  • SIMO Hong Kong
  • NTLA United States
  • Employees
  • SIMO N/A
  • NTLA N/A
  • Industry
  • SIMO Semiconductors
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SIMO Technology
  • NTLA Health Care
  • Exchange
  • SIMO Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • SIMO 2.4B
  • NTLA 794.5M
  • IPO Year
  • SIMO 2005
  • NTLA 2016
  • Fundamental
  • Price
  • SIMO $74.81
  • NTLA $10.68
  • Analyst Decision
  • SIMO Strong Buy
  • NTLA Buy
  • Analyst Count
  • SIMO 8
  • NTLA 19
  • Target Price
  • SIMO $80.63
  • NTLA $35.11
  • AVG Volume (30 Days)
  • SIMO 342.8K
  • NTLA 4.9M
  • Earning Date
  • SIMO 07-31-2025
  • NTLA 08-07-2025
  • Dividend Yield
  • SIMO 2.67%
  • NTLA N/A
  • EPS Growth
  • SIMO 59.19
  • NTLA N/A
  • EPS
  • SIMO 2.80
  • NTLA N/A
  • Revenue
  • SIMO $780,733,000.00
  • NTLA $45,569,000.00
  • Revenue This Year
  • SIMO $2.23
  • NTLA N/A
  • Revenue Next Year
  • SIMO $13.23
  • NTLA N/A
  • P/E Ratio
  • SIMO $26.75
  • NTLA N/A
  • Revenue Growth
  • SIMO 10.84
  • NTLA N/A
  • 52 Week Low
  • SIMO $37.21
  • NTLA $5.90
  • 52 Week High
  • SIMO $85.00
  • NTLA $28.18
  • Technical
  • Relative Strength Index (RSI)
  • SIMO 69.69
  • NTLA 69.70
  • Support Level
  • SIMO $73.09
  • NTLA $8.98
  • Resistance Level
  • SIMO $76.77
  • NTLA $11.08
  • Average True Range (ATR)
  • SIMO 2.11
  • NTLA 0.69
  • MACD
  • SIMO -0.02
  • NTLA 0.16
  • Stochastic Oscillator
  • SIMO 81.68
  • NTLA 88.96

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: